<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>NISCAIR Online Periodicals Repository Collection: JIPR Vol.13(4) [July 2008]</title>
    <link>http://nopr.niscair.res.in/handle/123456789/1725</link>
    <description />
    <textInput>
      <title>The Collection's search engine</title>
      <description>Search the Channel</description>
      <name>search</name>
      <link>http://nopr.niscair.res.in/simple-search</link>
    </textInput>
    <item>
      <title>Battling with TRIPS: Emerging Firm Strategies of Indian Pharmaceutical Industry Post-TRIPS</title>
      <link>http://nopr.niscair.res.in/handle/123456789/6062</link>
      <description>Title: Battling with TRIPS: Emerging Firm Strategies of Indian Pharmaceutical Industry Post-TRIPS
&lt;br/&gt;
&lt;br/&gt;Authors: Rai, Rajnish Kumar
&lt;br/&gt;
&lt;br/&gt;Abstract: The full&#xD;
scale compliance of TRIPS Agreement essentially represents a big step in the&#xD;
opposite direction as it effectively ended more than three decades of protection for Indian&#xD;
companies and terminated legal ‘reverse engineering’. The new patent regime throws a new challenge to the&#xD;
Indian pharmaceutical industry to maintain its competitiveness and profitability.&#xD;
This study investigates emerging firm strategies of the Indian pharmaceutical&#xD;
companies to overcome the challenge posed by new patent regime. The study&#xD;
concludes that the industry is witnessing a transition phase, and is undergoing&#xD;
consolidation and restructuring. The industry is adopting a mix of competitive&#xD;
and collaborative business and R&amp;D strategies in the emerging business&#xD;
environment
&lt;br/&gt;
&lt;br/&gt;Page(s): 301-317</description>
      <pubDate>Sat, 28 Jun 2008 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Patent Infringement: How to Minimize the Risk</title>
      <link>http://nopr.niscair.res.in/handle/123456789/1784</link>
      <description>Title: Patent Infringement: How to Minimize the Risk
&lt;br/&gt;
&lt;br/&gt;Authors: Singh, Amit
&lt;br/&gt;
&lt;br/&gt;Abstract: It is well known that research based pharmaceutical companies invest heavily in research and development (R&amp;D) of new chemical entities. Therefore, it is inevitable that with respect to development and/or launch of a new product or process without proper pre-emptive steps, unintentional infringement of intellectual property rights (IPR) can cause heavy losses. Such infringement will not only have impact on sales and revenue generation but also cause massive damage to the customer’s confidence and ultimately reputation of manufacturers. This article analyses basic and most pertinent question to be answered i.e. what measures should be taken to minimize the risk factor associated with the patent infringement issues?
&lt;br/&gt;
&lt;br/&gt;Page(s): 351-353</description>
      <pubDate>Sat, 28 Jun 2008 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>IP Case Law Developments</title>
      <link>http://nopr.niscair.res.in/handle/123456789/1783</link>
      <description>Title: IP Case Law Developments
&lt;br/&gt;
&lt;br/&gt;Authors: Thomas, Zakir
&lt;br/&gt;
&lt;br/&gt;Abstract: This article attempts to summarize some of the recently reported cases on intellectual property law to enable  readers to understand how the courts have applied the principles of intellectual property law to actual IP disputes. The cases are chosen from the cases reported in the March 2008 issue of the Patents and Trade Marks Cases (PTC), a leading case law reporter on intellectual property laws.
&lt;br/&gt;
&lt;br/&gt;Page(s): 344-350</description>
      <pubDate>Sat, 28 Jun 2008 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Institutions and Capacity Building for the Evolution of Intellectual Property Rights Regime in India: IV– Identification and Disclosure of IP Products for their IPR Protection in Plants and Animals</title>
      <link>http://nopr.niscair.res.in/handle/123456789/1782</link>
      <description>Title: Institutions and Capacity Building for the Evolution of Intellectual Property Rights Regime in India: IV– Identification and Disclosure of IP Products for their IPR Protection in Plants and Animals
&lt;br/&gt;
&lt;br/&gt;Authors: Kochhar, Sudhir
&lt;br/&gt;
&lt;br/&gt;Abstract: The recognition that plants and animals can provide commercial opportunities in agriculture and industry, and their inclusion as patentable subject matter in the TRIPS Agreement necessitates finer analyses and understanding of IPR protection of plants and animals and their products in agriculture. This paper attempts to analyse the scenario of a possible dual protection of indigenous plants and animals including farmers’ varieties under the sui generis IPR protection as varieties/breeds on the one hand and the geographical indications on the other hand.
&lt;br/&gt;
&lt;br/&gt;Page(s): 336-343</description>
      <pubDate>Sat, 28 Jun 2008 22:58:59 GMT</pubDate>
    </item>
  </channel>
</rss>

